ClearSign Technologies (CLIR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 Apr, 2026Executive summary
Annual meeting scheduled for June 8, 2026, at 1:00 p.m. Central Time, to be held virtually.
Shareholders are encouraged to review proxy materials and vote by June 7, 2026.
Voting matters and shareholder proposals
Election of four directors: Colin James Deller Ph.D, Louis J. Basenese, Anthony DiGiandomenico, and G. Todd Silva.
Advisory approval of BPM CPA LLP as independent auditor for the year ending December 31, 2026.
Approval of amended and restated 2021 Equity Incentive Plan.
Advisory vote on executive compensation (say-on-pay).
Approval for potential adjournment of the meeting to solicit additional proxies if needed.
Board of directors and corporate governance
Board recommends voting in favor of all proposals and director nominees.
Partial view of Summaries dataset, powered by Quartr API
Latest events from ClearSign Technologies
- Net loss widened to $2.19M in Q1 2026 as revenue fell 52% and warranty costs surged.CLIR
Q1 202615 May 2026 - Shareholders will vote on directors, auditor, equity plan, and executive pay, with Board support.CLIR
Proxy filing28 Apr 2026 - Low NOx burner technology gains momentum as key projects and demos drive order growth.CLIR
Water Tower Research Insights Conference15 Apr 2026 - Record revenue growth and expanding hydrogen-capable burner orders drive improved outlook.CLIR
Q4 20259 Apr 2026 - Both reverse stock split and adjournment proposals passed with strong shareholder support.CLIR
EGM 20269 Apr 2026 - Record revenue, robust pipeline, and expanding partnerships drive strong growth outlook.CLIR
Status update24 Feb 2026 - Stockholders to vote on a reverse stock split to maintain Nasdaq listing and enhance flexibility.CLIR
Proxy Filing2 Feb 2026 - Shareholders will vote on a reverse stock split to help maintain Nasdaq listing and board flexibility.CLIR
Proxy Filing23 Jan 2026 - Q2 2024 saw revenue fall, net loss rise, and cash surge on equity raises amid major new orders.CLIR
Q2 202423 Jan 2026